Keywords: CE FS T1WI; contrast-enhanced fat-suppressed T1-weighted images; FS; fat-suppressed; HNSCC; head and neck squamous cell carcinoma; MRI; magnetic resonance imaging; SCSG(s); superior cervical sympathetic ganglion (ganglia); ICA; internal carotid artery; TI
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: neutrophils; neutrophil-to-lymphocyte ratio; HNSCC;
Keywords: Maxilla; HNSCC; OSCC; Metastasis; Recurrence;
Keywords: HNSCC; TSH; Dose-volume parameters; Radiation-induced HT;
Keywords: Head and neck; Squamous cell carcinoma; HNSCC; Oropharyngeal; OPSCC; Tonsil; Base of tongue; Ultrasound;
Keywords: HNSCC; head and neck squamous cell carcinomas; OPSCC; oropharyngeal squamous cell carcinoma; DWI; diffusion weighted magnetic resonance imaging; TMA; tissue microarray; CI; confidence interval; ADC; apparent diffusion coefficient; Oropharyngeal neoplasms;
Keywords: HNSCC; Cetuximab; Cixutumumab; EGFR; IGF; Targeted therapy;
Keywords: Death receptor; NF-κB; Caspase-8; HNSCC; TNFR; TRAIL;
Keywords: Oral squamous cell carcinoma; Head and neck cancer; Tongue cancer; OPLS-DA; Tissue proteomics; CA1; S100A7; Neutrophil defensin 1; ANP32B; Immunohistochemistry; ALYREF; THO complex subunit 4; ANP32B; Acidic leucine-rich nuclear phosphoprotein 32 family me
Keywords: Small molecules; biologics; adverse effects mouth; BP; Bisphosphonates; EGFR; Epidermal growth factor receptor; FDA; Food and Drug Administration; HER2; Human epidermal growth factor receptor 2; HNSCC; Head and neck squamous cell carcinoma; mAbs; Monoclon
Keywords: Esophageal Cancer; Genomics; Epigenomics; ADAR; adenosine deaminases acting on RNA; APOBEC; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; BCH; basal cell hyperplasia; CIS; carcinoma in situ; CNA; copy number alteration; ESCC; esophagea
Keywords: HNSCC; head and neck squamous cell carcinoma; R/M; recurrent and/or metastatic; ICPi; immune checkpoint inhibitor; irAE; immune-related adverse event; Gy; gray; MRC; Medical Research Council; CK; creatinine kinase; U/L; units per Liter; AST; aspartate tra
Keywords: 5mC; 5-methylcytosine; a-DMR; age-differentially methylated region; Avy; agouti viable yellow; cfDNAs; cell-free DNA; COBRA; combined bisulfite restriction analysis; ERE; endogenous retroelement; ETns; early transposons; hADSC; human adipose derived mesen
Keywords: ABMDMA; 9,10-anthracenediyl-bis(methylene)dimalonic acid; chol; cholesterol; DMEM; Dulbecco's modified Eagle's medium; DMEM/F12; Dulbecco's modified Eagle's medium supplemented with Ham's Nutrient Mixture F12; DMF; Dimethylformamide; DMSO; Dimet
Keywords: ACC; acetyl-CoA carboxylase; ALDOA; aldolase A; AIs; aromatase inhibitors; AMPK; AMP-activated protein kinase; BC; breast cancer; CML; chronic myelogenous leukemia; CT; computed tomography; CPT1; carnitine palmitoyltransferase 1; CRC; colorectal cancer; 2
Keywords: HNSCC; head and neck squamous cell carcinoma; HSP; heat shock proteins; LSCC; laryngeal squamous cell carcinoma; MAF; minor allelic frequency; OLP; oral lichen planus; OLD; oral lichenoid disease; OLL; oral lichenoid lesion; OR; odd ratio; OSCC; oral squa
Keywords: ADC; apparent diffusion coefficient; AUC; area under curve; DDC; distributed diffusion coefficient; DKI; diffusion kurtosis imaging; DWI; diffusion-weighted image; EPI; echo-planar imaging; HNSCC; head and neck squamous cell carcinoma; IVIM; intravoxel in
Keywords: AUC; Area under the ROC curve; Death NED; Death with no evidence of disease; DM; Distant metastasis; CI; Confidence interval; FDG; 18F-fluorodeoxyglucose; HNSCC; Head and neck squamous cell carcinoma; HPV; Human papilloma virus; IMRT; intensity-modulated
Keywords: Intravoxel incoherent motion; MRI; DWI; HNSCC; Lymph node metastasis;
Keywords: BIA; Bioimpedance; BMI; Body mass index; BMR; Basal metabolic rate; CRP; C-reactive protein; CT; Computerized tomography; CTCAE; Common Terminology Criteria for Adverse Events; ESPEN; European Society for Enteral and Parenteral Nutrition; FFM; Fat free ma
Keywords: Head and neck cancer; Survival; Treatment delay; HNSCC; head-and-neck squamous cell carcinoma; CI; confidence intervals; FVG-CR; Friuli Venezia Giulia Cancer Registry; HR; multivariate hazard ratio; TTI; time to treatment initiation;
Keywords: Sarcopenia; Skeletal muscle mass; Lean body mass; Head and neck neoplasms; Radiochemotherapy; Chemotherapy dose-limiting toxicity; Computer-assisted image analysis; SMM; skeletal muscle mass; CDLT; chemotherapy dose-limiting toxicity; HNSCC; head and neck
Keywords: Head and neck cancer; HNSCC; Patient derived xenograft; PDX; Mouse model;
Keywords: ADO; adenosine; CFSE; carboxyfluorescein succinimidyl ester; HNSCC; head and neck squamous cell cancer; HO-1; heme oxygenase 1; IDO; indoleamine 2â²3 dioxygenase; MSC; mesenchymal stromal cells; PBMC; peripheral blood mononuclear cells; PGE2; prostagland
Keywords: DESI; desorption electrospray ionization; ESI; electrospray ionization; H&E; hematoxylin and eosin; HNSCC; head and neck squamous cell carcinoma; LR; logistic regression; LOPOCV; leave-one-patient-out cross validation; MMP9; matrix metalloproteinase 9; MS
Keywords: CSC; cancer stem cells; DCLK1; doublecortin-like kinase 1; DMSO; dimethyl sulfoxide; DFS; disease-free survival; HNSCC; head and neck squamous cell carcinoma; HPSCC; hypopharyngeal squamous cell carcinoma; HPV; human papilloma virus; LRRK-2-in-1; leucine
Keywords: HNSCC; Squamous cell carcinoma; Oropharyngeal; HPV; Viral integration; Chromatin;
Keywords: Clinical trial; cancer imaging; study design; statistical analysis; ACRIN; American College of Radiology Imaging Network; CT; computed tomography; ER; estrogen receptor; FDG; [18F]-fluorodeoxyglucose; FDG-PET; positron emission tomography with [18F]-fluor
Keywords: HDAC; PTEN; HNSCC; PI3K/Akt/mTOR; Drug design; Anti-cancer;
Keywords: APC; adenomatous polyposis coli; AR; androgen receptor; CAFs; cancer-associated fibroblasts; CTL; cytotoxic T cells; EMT; epithelial-mesenchymal transition; EPCs; endothelial progenitor cells; FSP1; fibroblast specific protein 1; HNSCC; head and neck sq
Keywords: ABC; ATP binding cassette; ADCC; antibody-dependent cell-mediated cytotoxicity; ALDH; aldehyde dehydrogenase; CBP; cAMP response element binding protein (CREB)-binding protein; CSC; cancer stem cell; CTC; circulating tumour cell; DAPT; N-[N-(3,5-difluorop
Keywords: Adr; Adriamycin; miRNA; microRNA; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; mRNA; messenger RNA; RT-qPCR; real-time quantitative PCR; KEGG; Kyoto Encyclopedia of Genes and Genomes; PPI; protein-protein interaction; CHOL; cholest
Keywords: 2-DG; 2-deoxyglucose; 2-HG; 2-hydroxyglutarate; 5mC; 5-methlycystosine; ACACA; acetyl-CoA carboxylase; AML; acute myeloid leukemia; AMPK; adenosine monophosphate-activated protein kinase; ATP; adenosine triphosphate; ALDH; aldehyde dehydrogenase; ADCs; an
Keywords: Biomakers; Oral cancer; Saliva; Serum; OSCC; OC; HNSCC
Keywords: Langerhans cell; HNSCC; HPV; Prognosis; Multivariate analysis;
Keywords: CT; computed tomography; HNSCC; head and neck squamous cell carcinoma; HPV; human papillomavirus; HR; hazard ratio; IC; induction chemotherapy; IHC; immunohistochemical; IMRT; intensity-modulated radiotherapy; ISH; in situ hybridization; OPSCC; oropharyng
Keywords: NGS technology; Target genes; Tumour heterogeneity; Genetic complexity; Personalised medicine; HNSCC;
Keywords: CFE; colony forming efficiency; CIN; chromosomal instability; CSC; cancer stem cell; ELDA; extreme limiting dilution assessment; FISH; fluorescence in situ hybridization; HNSCC; head and neck squamous cell carcinoma; IR; ionizing radiation; NSCLC; non-sma
Keywords: Cancer stem-like cells; Mevalonate cascade; Ras; Rho; Stemness; Statins; Yap; ACAT; acetoacetyl-CoA transferase; acetyl-CoA; acetyl-coenzyme A; Arp2/3; actin-related protein 2/3 (actin polymerizing complex); BPs; bisphosphonates; CAMs; cell adhesion molec
Keywords: Afatinib; Colorectal cancer; EGFR; Combination therapy; AE; adverse events; CLX; cell line xenograft; CR; complete response; (m)CRC; (metastatic) colorectal cancer; EGFR; epidermal growth factor receptor; GI; gastrointestinal; HNSCC; head and neck squamou
Keywords: O3; ozone; OH; hydroxyl; H2O2; hydrogen peroxide; O; oxygen; NxOy; nitrogen oxides of different oxidation states; NOS; nitric oxide synthase; Ar; argon; He; helium; UV; ultraviolet; CAP; cold atmospheric plasma; ACP; atmospheric cold plasma; APP; cold atm
Keywords: CBL; casitas B-lineage lymphoma; CtxR; cetuximab-resistant; CtxS; cetuximab-sensitive; CRC; colorectal cancer; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMT; epithelial to mesenchymal transition; EPR; epiregulin; FDA; food and
Keywords: Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: Tongue carcinoma; Oral cancer; Immunohistochemistry; Prognosis; Recurrence; Survival; Invasion; Metastasis; p16 protein; DFS; disease-free survival; DSS; disease-specific survival; HNSCC; head and neck squamous cell carcinoma; HPV; human papilloma virus;
Keywords: Head and neck cancer; HNSCC; Head and neck squamous cell carcinoma; Waiting time; Treatment delay; Prognosis; Survival;
Keywords: SPC; second primary cancer; HNSCC; head and neck squamous cell carcinoma; OS; overall survival; NS; net survival; HR; Hazard ratios; 95% CI; 95% confidence interval; m; months; y; years; ref; reference category; Head and neck cancer; Survival; Neoplasms;
Keywords: FACT-EF; Functional Assessment of Cancer Therapy-Enteral Feeding [questionnaire]; HNSCC; head and neck squamous-cell carcinoma; NRS; numeric rating scale; PEG; percutaneous endoscopic gastrostomy; PG; pigtail gastrostomy; POG; peroral image-guided gastr
Keywords: ERK; extracellular signal-regulated kinase; EGFR; epidermal growth factor receptor; ELISA; enzyme-linked immunosorbent assay; FFPE; formalin-fixed paraffin-embedded; FISH; fluorescence in situ hybridization; FNA; fine-needle aspiration; F/RPPA; forward/re
Keywords: Celecoxib; Cetuximab; COX-2; HNSCC; ET-1; NGF
Keywords: HNSCC; Immunotherapy; CTLA-4; PD-1; Cetuximab; Vaccine; Chimeric antigen receptor;